CVS Health Corporation (CVS) Updates its Commercial Formularies

CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced ...

CVS Caremark Expands Biosimilar Adoption Through Formulary Updates to Improve Affordability and Access

CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars across multiple therapeutic categories, including ...
Kalkine Media

S&P 500 Index: Is CVS Health Reshaping Healthcare Logistics?

S&P 500 Index attention surrounds CVS Health after Omnicare divestiture, drone healthcare logistics expansion, and biosimilar ...

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

Q1 2026 Management view “We are off to a strong start in 2026... building momentum across the business,” said (Co-Founder, President, CEO & Director Richard Lowenthal), highlighting priorities of ...

CVS Profits Eclipse $2.9 Billion As Aetna Health Plan Costs Ease

CVS Health reported first quarter net income of more than $2.9 billion as costs slowed for subscribers of the Aetna health plans the company sells.